Study S000026

A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Liraglutide vs. a Sulphonylurea

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02292290
Acronym: T4R
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 99
Start: 2011-04
Primary completion: 2012-12
Lead sponsor: University of Leicester
Conditions: Type 2 Diabetes
Interventions: DRUG:Liraglutide; DRUG:Sulfonylurea or Pioglitazone; DRUG:Maintain dual therapy (Sulf/Pio) as comparator to Liraglutide
Results posted: FALSE

Registered primary outcomes

Composite [12 weeks following post Ramadan cinical assessment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.